The University of North Texas Health Science Center is a public academic health science center in Fort Worth, Texas. It is part of the University of North Texas System and was founded in 1970 as the Texas College of Osteopathic Medicine.

During the past decade, University of North Texas Health Science Center conducted 25 clinical trials. In the 10-year time frame, 25 clinical trials started and 15 clinical trials were completed, i.e. on average, 60% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 7 clinical trials were completed. i.e. 87.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of North Texas Health Science Center" #1 sponsor was "Centers for Disease Control and Prevention" with 17 trials, followed by "University of North Texas Health Science Center" with 16 trials sponsored, "Pfizer" with 5 trials sponsored, "JANSSEN Alzheimer Immunotherapy Research & Development, LLC" with 3 trials sponsored and "Boehringer Ingelheim" with 3 trials sponsored. Other sponsors include 17 different institutions and companies that sponsored additional 25 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of North Texas Health Science Center" #1 collaborator was "US Department of Veterans Affairs" with 11 trials as a collaborator, "American Osteopathic Association" with 4 trials as a collaborator, "National Institute on Aging (NIA)" with 3 trials as a collaborator, "National Institute on Alcohol Abuse and Alcoholism (NIAAA)" with 3 trials as a collaborator and "Pfizer" with 3 trials as a collaborator. Other collaborators include 52 different institutions and companies that were collaborators in the rest 54 trials.

According to Clinical.Site data, the most researched conditions in "University of North Texas Health Science Center" are "Tuberculosis" (13 trials), "Alzheimer's Disease" (6 trials), "HIV Infections" (5 trials), "Chronic Low Back Pain" (4 trials) and "Alzheimer Disease" (3 trials). Many other conditions were trialed in "University of North Texas Health Science Center" in a lesser frequency.

Most popular intervention types in "University of North Texas Health Science Center" are "Drug" (37 trials), "Other" (10 trials), "Behavioral" (7 trials), "Biological" (4 trials) and "Procedure" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (12 trials), "Isoniazid" (4 trials), "Rifabutin" (4 trials), "Bapineuzumab 0.5 mg/kg" (2 trials) and "Bapineuzumab 1.0 m/kg" (2 trials). Other intervention names were less common.

The vast majority of trials in "University of North Texas Health Science Center" are 63 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are 9 active trials in "University of North Texas Health Science Center". 3 are not yet recruiting, 4 are recruiting, 1 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 49 completed trials in University of North Texas Health Science Center, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in University of North Texas Health Science Center, 0 "Phase 1" clinical trials were conducted, 10 "Phase 2" clinical trials and 22 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 20 trials that are defined as “Not Applicable".